More combination therapy seems a likely way forward, paralleling
the trend of therapeutic modalities in viral infections and in cancer
treatments. In that eventuality, coupling real-time diagnostics of the
pathogen population in each patient to a proven or predictively
effective combination of antibiotics may be a way forward, although
Kishony and coworkers have noted the downside potential for
resistance development in combination approaches.